Earnings Call Transcripts

Access detailed transcripts and key takeaways from company earnings calls

All Earnings Calls

GIL April 30, 2026

Gildan Activewear Q1 2026 Earnings Call - Hanes Integration Drives Record Sales Amid Margin Pressure and Synergy Execution

Gildan Activewear delivered record Q1 2026 sales of $1.17 billion, up 64% year-over-year, driven almost entirely by the full consolidation of HanesBrands. Adjusted diluted EPS came in at $0.43, down f...

  • Record Q1 2026 sales of $1.17 billion, up 64% year-over-year, driven by the full consolidation of HanesBrands acquisition.
  • Adjusted diluted EPS of $0.43, down from $0.59 in Q1 2025, reflecting integration costs, higher SG&A, and a $106 million inventory fair value step-up charge.
  • Management reaffirmed $100 million in synergies for 2026 and $250 million over three years, treating synergy capture as an investment in future innovation and growth.
  • +7 more takeaways
CROX April 30, 2026

Crocs (CROX) Q1 2026 Earnings Call - Strong DTC Momentum Offsets Wholesale Slump, Guidance Raised Amid Tariff & Geopolitical Headwinds

Crocs delivered a better-than-expected first quarter of 2026, with enterprise revenue of $921 million slightly beating consensus. The Crocs brand saw a modest 2% reported decline, while HEYDUDE contra...

  • Enterprise revenue of $921 million beat expectations, driven by strong direct-to-consumer performance across both brands.
  • Crocs brand revenue declined 2% reported, while HEYDUDE fell 13%, as the company continues to manage wholesale inventory levels.
  • Direct-to-consumer growth was a standout, with Crocs DTC up 11% and HEYDUDE DTC up 8%, despite reduced promotional and marketing spend.
  • +7 more takeaways
IRT April 30, 2026

Independence Realty Trust Q1 2026 Earnings Call - Asking Rents Surge as Supply Eases and Wi-Fi Initiative Accelerates

Independence Realty Trust delivered a solid start to 2026, with same-store NOI growing 1% and core FFO per share landing at $0.26, perfectly in line with expectations. The real story is the rapid norm...

  • Same-store NOI grew 1% and core FFO per share came in at $0.26, meeting guidance and reflecting stable 95.2% occupancy.
  • Asking rents jumped 2.8% year-to-date, with significant outperformance in Raleigh (5.7%), Indianapolis (5.2%), and Nashville (4.5%).
  • Management is shifting strategy from prioritizing occupancy to aggressively capturing rental rate growth as supply pressures ease.
  • +7 more takeaways
AXS April 30, 2026

AXIS Capital Q1 2026 Earnings Call - Disciplined Growth and Portfolio Shifts Amid Market Softening

AXIS Capital delivered a strong first quarter in 2026, driven by disciplined underwriting and strategic portfolio shifts. Gross written premiums surged 11% to $3.1 billion, with insurance growth accel...

  • Gross written premiums reached $3.1 billion, up 11% year-over-year, driven by strong performance in insurance and expanded specialty lines.
  • Insurance segment gross written premiums surged 20% year-over-year, with underlying portfolio growth in the low single digits and expanded classes contributing high single-digit growth.
  • AXIS Capacity Solutions (ACS) contributed significantly to premium growth, including new Funds at Lloyd’s (FAL) transactions and strategic reinsurance vehicles, accounting for approximately 10 points of growth.
  • +7 more takeaways
CI April 30, 2026

Cigna Group Q1 2026 Earnings Call - Raising Full-Year EPS Outlook Amid Strategic Portfolio Shifts and AI-Driven Innovation

Cigna Group delivered a strong first quarter, driving a raise in its full-year 2026 adjusted EPS outlook to at least $30.35. The results were fueled by robust growth in its Specialty and Care Services...

  • Cigna Group raised its full-year 2026 adjusted EPS outlook to at least $30.35, citing strong first-quarter momentum and disciplined execution across its core platforms.
  • First-quarter revenue reached $68.5 billion, with adjusted EPS of $7.79, reflecting a 16% year-over-year growth rate and resilience in a cost-inflated environment.
  • CEO David Cordani is transitioning to Executive Chair on July 1, with President and COO Brian Evanko succeeding him, marking a leadership handoff after 17 years at the helm.
  • +9 more takeaways
OPCH April 30, 2026

Option Care Health Q1 2026 Earnings Call - CID Portfolio Reset Drives Revenue Miss But EBITDA Guidance Holds

Option Care Health delivered a mixed first quarter as its chronic inflammatory disease (CID) portfolio faced an unexpected census reset. Revenue grew just 1%, missing expectations, while a higher-than...

  • Revenue grew just 1% year-over-year to $1.4 billion, missing top-line expectations as chronic therapy headwinds overwhelmed acute strength.
  • CID portfolio reset drove a $55 million gross profit headwind, up from the prior $25-35 million estimate, due to patient attrition and unfavorable therapy mix.
  • Acute therapy revenue accelerated in the high single digits, outpacing market growth and offsetting part of the chronic weakness.
  • +7 more takeaways
CAH April 30, 2026

Cardinal Health Q3 FY2026 Earnings Call - Specialty Growth and Cash Flow Raise Offset Pharma Revenue Mix Shifts

Cardinal Health delivered a robust third quarter, driven by broad-based demand and disciplined execution across its portfolio. Pharmaceutical and Specialty Solutions led the charge, with revenue up 11...

  • Total company revenue grew 11% year-over-year to $61 billion, driven by strong demand in Pharmaceutical and Specialty Solutions and Other Growth Businesses.
  • Pharmaceutical and Specialty Solutions segment profit rose 18% to $784 million, outpacing revenue growth due to favorable mix in brand and specialty products.
  • Specialty revenue grew over 20%, with the business on track to exceed $50 billion in fiscal 2026, supported by acquisitions like Solaris and strategic MSO expansions.
  • +7 more takeaways
ICE April 30, 2026

Intercontinental Exchange (ICE) Q1 2026 Earnings Call - Record Revenue and EPS Drive by Structural Energy and Data Demand

Intercontinental Exchange delivered its strongest quarter in company history, with record net revenues of $3 billion, up 18%, and adjusted EPS of $2.35, up 37%. The results were powered by a convergen...

  • Record net revenues of $3 billion, up 18% year-over-year, and adjusted EPS of $2.35, up 37%, mark the strongest quarter in ICE history.
  • Exchange segment revenues reached a record $1.8 billion, up 27%, driven by 33% growth in transaction revenues, with interest rate complexes up nearly 70% and global oil complexes up 47% year-over-year.
  • Energy open interest through April remains up 6%, and interest rate open interest stands 63% above year-ago levels, indicating structural expansion in risk management demand rather than transient speculation.
  • +7 more takeaways
CGAU April 30, 2026

Centerra Gold Q1 2026 Earnings Call - Self-Funded Growth Pipeline and Record Cash Flow

Centerra Gold delivered a robust first quarter, generating $49 million in free cash flow and bolstering its cash balance to $543 million. The company’s operations at Mount Milligan and Öksüt performed...

  • Centerra Gold generated $49 million in free cash flow and $120 million in operating cash flow in Q1 2026, driven by strong performance at Mount Milligan and Öksüt.
  • Cash balance increased to $543 million, bringing total liquidity to $943 million, providing ample funding for self-directed growth projects.
  • Mount Milligan produced 29,500 ounces of gold and 14.2 million pounds of copper, with AISC of $1,060/oz on a byproduct basis.
  • +7 more takeaways
BAX April 30, 2026

Baxter International Q1 2026 Earnings Call - Turnaround Gains Traction Amid Novum Hold and Margin Pressure

Baxter International delivered Q1 2026 results in line with expectations, reporting $2.7B in sales from continuing operations and adjusted EPS of $0.36, down 35% year-over-year. The quarter reflected ...

  • Q1 2026 sales from continuing operations totaled $2.7B, up 3% reported and down 1% organic, with adjusted EPS of $0.36, a 35% decline year-over-year.
  • Management reiterated full-year 2026 guidance: flat to 1% reported sales growth and $1.85–$2.05 adjusted EPS, driven by back-half improvement.
  • Novum LVP shipment and installation hold remains in place for 2026, with potential customer returns prudently factored into guidance despite no material impact in Q1.
  • +12 more takeaways